Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Limited engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China. It focusses on various therapeutic areas, in…
Biotechnology
CN, Nanjing [HQ]
Balance Sheet
8 Sheets · From 2023 to 2012Configuration
In Million CNY. Margins, Growth Rates In %
| Metric | 2012 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets | 3,372.00 | 5,195.00 | 6,338.00 | 6,766.00 | 10,943.00 | 10,161.00 | 10,781.00 | 10,853.00 | |
|
Current
|
1,743.00 | 2,784.00 | 3,665.00 | 2,897.00 | 6,466.00 | 4,979.00 | 5,453.00 | 5,638.00 | |
| Cash And Equivalents | 178.00 | 572.00 | 1,187.00 | 354.00 | 3,270.00 | 973.00 | 1,657.00 | 2,007.00 | |
| Assets | 3,372.00 | 5,195.00 | 6,338.00 | 6,766.00 | 10,943.00 | 10,161.00 | 10,781.00 | 10,853.00 | |
| Accounts Receivables (AR) | 184.00 | -26.00 | -254.00 | -386.00 | -542.00 | -545.00 | 74.00 | -322.00 | |
| Inventory | 120.00 | 187.00 | 233.00 | 248.00 | 262.00 | 235.00 | 302.00 | 614.00 | |
| Short Term Investments | - - | 509.00 | 263.00 | 546.00 | 3.00 | 1,210.00 | 964.00 | 11.00 | |
| Other Current Assets | 350.00 | 788.00 | 999.00 | 361.00 | 1,014.00 | 106.00 | 125.00 | 361.00 | |
|
Non Current
|
1,544.00 | 2,410.00 | 2,672.00 | 3,869.00 | 4,476.00 | 5,181.00 | 5,327.00 | 5,214.00 | |
| Property, Plant, Equipment (Net) | 840.00 | 1,186.00 | 1,397.00 | 1,934.00 | 2,191.00 | 1,961.00 | 2,171.00 | 2,191.00 | |
|
Intangible Assets
|
362.00 | 65.00 | 49.00 | 33.00 | 77.00 | 59.00 | 379.00 | 715.00 | |
| Goodwill | 284.00 | 142.00 | 142.00 | 142.00 | 172.00 | 172.00 | 172.00 | 142.00 | |
| Long Term Investments | 56.00 | 986.00 | 1,035.00 | 676.00 | 1,771.00 | 1,441.00 | 2,555.00 | 1,579.00 | |
| Other Non Current Assets | -1,544.00 | -164.00 | -125.00 | 807.00 | 53.00 | 1,256.00 | -279.00 | 268.00 | |
| Liabilities | 1,300.00 | 3,413.00 | 4,773.00 | 5,286.00 | 5,607.00 | 3,698.00 | 3,638.00 | 3,630.00 | |
|
Current
|
1,209.00 | 2,531.00 | 4,111.00 | 3,428.00 | 3,497.00 | 3,063.00 | 2,963.00 | 2,685.00 | |
| Accounts Payable | - - | - - | - - | 386.00 | 542.00 | 545.00 | -74.00 | - - | |
| Short Term Debt | - - | 1,014.00 | 2,196.00 | 1,670.00 | 1,831.00 | 1,561.00 | 1,350.00 | 1,094.00 | |
| Deferred Revenue | - - | -1,479.00 | -2,723.00 | - - | - - | - - | -1,697.00 | -79.00 | |
| Tax Payable | - - | 69.00 | 173.00 | 145.00 | 60.00 | 92.00 | 144.00 | 170.00 | |
| Other Current Liabilities | 1,147.00 | 2,781.00 | 4,330.00 | 1,503.00 | 1,424.00 | 1,178.00 | 2,975.00 | 1,353.00 | |
|
Non Current
|
2.00 | 882.00 | 661.00 | 1,857.00 | 2,110.00 | 634.00 | 674.00 | 945.00 | |
| Long Term Debt | 2.00 | 303.00 | 121.00 | 1,270.00 | 1,468.00 | 74.00 | 155.00 | 334.00 | |
| Leasing Obligations | - - | 25.00 | 56.00 | 157.00 | 231.00 | 105.00 | 214.00 | 208.00 | |
| Deferred Non Current Tax Liabilities | - - | 232.00 | 208.00 | 116.00 | 193.00 | 142.00 | 115.00 | 102.00 | |
| Other Non Current Liabilities | -2.00 | 2.00 | 1.00 | - - | - - | - - | - - | 115.00 | |
| Equity | 2,072.00 | 1,781.00 | 1,565.00 | 1,480.00 | 5,335.00 | 6,462.00 | 7,142.00 | 7,222.00 | |
| Stockholders' Equity | 2,012.00 | 1,779.00 | 1,565.00 | 1,480.00 | 5,301.00 | 6,436.00 | 7,126.00 | 7,222.00 | |
| Retained Earnings | 1,254.00 | 1,517.00 | 1,249.00 | 1,465.00 | 2,147.00 | 2,601.00 | 3,061.00 | 3,837.00 | |
| Common Stock | 8.00 | - - | - - | - - | 3,002.00 | 3,002.00 | 3,081.00 | 3,173.00 | |
| Preferred Stock | - - | - - | - - | - - | - - | - - | - - | - - | |
| Profit | 56.00 | 350.00 | 733.00 | 1,003.00 | 669.00 | 1,507.00 | 930.00 | 714.00 | |
| Dividends | - - | - - | -549.00 | -912.00 | - - | -391.00 | -391.00 | -419.00 | |
| Minority Interest | 60.00 | 2.00 | - - | - - | 33.00 | 25.00 | 16.00 | - - | |
| Other Stockholders' Equity | 749.00 | -253.00 | -151.00 | - - | - - | 692.00 | 774.00 | -3,837.00 | |
| Loss Other Compr. Income | - - | 515.00 | 467.00 | 14.00 | 151.00 | 139.00 | 209.00 | 4,048.00 |